We are live on ! Find out more
MCM

Monarch Capital Management Portfolio holdings

AUM $436M
1-Year Est. Return 26.61%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+26.61%
3 Year Est. Return
+65.03%
5 Year Est. Return
+87.16%
10 Year Est. Return
+267.35%
AUM
$277M
AUM Growth
+$17M
Cap. Flow
+$5.67M
Cap. Flow %
2.04%
Top 10 Hldgs %
30.68%
Holding
105
New
7
Increased
56
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$781K
2
CB icon
Chubb
CB
+$756K
3
ABBV icon
AbbVie
ABBV
+$457K
4
VOD icon
Vodafone
VOD
+$418K
5
EMR icon
Emerson Electric
EMR
+$417K

Sector Composition

Rank Sector Weight
1 Healthcare 20.82%
2 Consumer Staples 18.76%
3 Industrials 13.99%
4 Technology 12.48%
5 Financials 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$443B
$4.31M 1.55%
75,489
+8,208
+12% +$457K
ACN icon
27
Accenture
ACN
$102B
$4.29M 1.55%
37,150
+360
+1% +$37K
USB icon
28
US Bancorp
USB
$98.2B
$4.13M 1.49%
101,705
+5,184
+5% +$207K
PEP icon
29
PepsiCo
PEP
$190B
$4.08M 1.47%
39,808
+1,148
+3% +$113K
CINF icon
30
Cincinnati Financial
CINF
$27.3B
$4.06M 1.46%
62,054
-1,501
-2% -$91.4K
PFE icon
31
Pfizer
PFE
$143B
$3.97M 1.43%
141,241
-7,169
-5% -$205K
WFC icon
32
Wells Fargo
WFC
$261B
$3.7M 1.33%
76,533
+6,340
+9% +$310K
SYK icon
33
Stryker
SYK
$125B
$3.63M 1.31%
33,847
+1,100
+3% +$108K
NEE icon
34
NextEra Energy
NEE
$181B
$3.23M 1.16%
109,148
-20
-0% -$561
ZBH icon
35
Zimmer Biomet
ZBH
$18.2B
$3.19M 1.15%
30,793
+2,209
+8% +$214K
VWO icon
36
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$3.12M 1.12%
90,234
+3,500
+4% +$110K
FLS icon
37
Flowserve
FLS
$9.71B
$2.98M 1.07%
67,080
+6,380
+11% +$263K
T icon
38
AT&T
T
$159B
$2.96M 1.07%
100,186
+2,172
+2% +$60.2K
AFL icon
39
Aflac
AFL
$64.9B
$2.93M 1.06%
92,894
+8,934
+11% +$265K
BP icon
40
BP
BP
$116B
$2.75M 0.99%
108,302
+11,544
+12% +$291K
STLD icon
41
Steel Dynamics
STLD
$36B
$2.53M 0.91%
112,245
+2,550
+2% +$48.1K
VOD icon
42
Vodafone
VOD
$36.3B
$2.51M 0.9%
78,248
+13,410
+21% +$418K
CVX icon
43
Chevron
CVX
$392B
$2.3M 0.83%
24,067
+1,650
+7% +$144K
DIS icon
44
Walt Disney
DIS
$167B
$2.3M 0.83%
23,122
MDLZ icon
45
Mondelez International
MDLZ
$79.5B
$2.26M 0.81%
56,321
-570
-1% -$23.2K
GPC icon
46
Genuine Parts
GPC
$17.1B
$2.08M 0.75%
20,899
+39
+0.2% +$3.46K
SLB icon
47
SLB Ltd
SLB
$73.6B
$2.08M 0.75%
28,169
+265
+0.9% +$18.6K
BMY icon
48
Bristol-Myers Squibb
BMY
$133B
$1.97M 0.71%
30,764
-645
-2% -$40.7K
VRA icon
49
Vera Bradley
VRA
$97M
$1.78M 0.64%
87,333
-300
-0.3% -$4.91K
NTRS icon
50
Northern Trust
NTRS
$33.3B
$1.75M 0.63%
26,899
-70
-0.3% -$4.39K

Similar funds

Monarch Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Monarch Capital Management held 105 positions worth $277M, up 6.5% from $260M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Monarch Capital Management's Q1 2016 filing shows 7 new, 56 increased, 16 reduced and 5 closed positions. Its largest new stake was Gilead Sciences: 8,665 shares worth $796K. The largest sale was CHUBB CORPORATION, an estimated $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Staples and Industrials.

  • Monarch Capital Management's largest Q1 2016 buy was Gilead Sciences: 8,665 shares worth $796K.
  • Monarch Capital Management added most to AbbVie in Q1 2016, an estimated $457K increase.
  • Monarch Capital Management's biggest Q1 2016 reduction was Sysco, cutting an estimated $303K.
  • Monarch Capital Management fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $1.45M.
  • Monarch Capital Management's ten largest holdings make up 31% of its $277M portfolio in Q1 2016.
  • Monarch Capital Management opened 7 new positions and closed 5 in Q1 2016.
  • Monarch Capital Management's portfolio value rose 6.5% quarter-over-quarter to $277M.

Based on Monarch Capital Management's 13F filing for Q1 2016, filed 19 Apr 2016.